Ziopharm Oncology
ZIOP
#8592
Rank
A$0.27 B
Marketcap
A$1.30
Share price
-0.88%
Change (1 day)
-76.71%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -A$0.12 Billion

According to Ziopharm Oncology's latest financial reports the company's current earnings are A$3.73 Million. In 2020 the company made an earning of -A$0.12 Billion a decrease over its 2019 earnings that were of -A$86.13 Million.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$0.12 Billion-0.49%
2020-A$0.12 Billion38.89%
2019-A$86.13 Million7.33%
2018-A$80.25 Million0.77%
2017-A$79.63 Million-67.64%
2016-A$0.25 Billion37.64%
2015-A$0.18 Billion176.1%
2014-A$64.76 Million-24.63%
2013-A$85.92 Million-43.51%
2012-A$0.16 Billion43.09%
2011-A$0.11 Billion190.88%
2010-A$36.54 Million102.46%
2009-A$18.05 Million-52.68%
2008-A$38.14 Million-10.33%
2007-A$42.54 Million15.35%
2006-A$36.88 Million355.36%
2005-A$8.1 Million13788.35%
2004-A$0.06 Million9.27%
2003-A$0.06 Million-10.26%
2002-A$0.06 Million-59.35%
2001-A$0.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.27 B-9,334.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.95 B-9,098.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-A$4.1 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.41 Billion 202.45%๐Ÿ‡บ๐Ÿ‡ธ USA